741 related articles for article (PubMed ID: 23508784)
1. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
2. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
Witjas-Paalberends ER; Piroddi N; Stam K; van Dijk SJ; Oliviera VS; Ferrara C; Scellini B; Hazebroek M; ten Cate FJ; van Slegtenhorst M; dos Remedios C; Niessen HW; Tesi C; Stienen GJ; Heymans S; Michels M; Poggesi C; van der Velden J
Cardiovasc Res; 2013 Aug; 99(3):432-41. PubMed ID: 23674513
[TBL] [Abstract][Full Text] [Related]
3. Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function.
van Dijk SJ; Paalberends ER; Najafi A; Michels M; Sadayappan S; Carrier L; Boontje NM; Kuster DW; van Slegtenhorst M; Dooijes D; dos Remedios C; ten Cate FJ; Stienen GJ; van der Velden J
Circ Heart Fail; 2012 Jan; 5(1):36-46. PubMed ID: 22178992
[TBL] [Abstract][Full Text] [Related]
4. ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease.
Sequeira V; Najafi A; Wijnker PJ; Dos Remedios CG; Michels M; Kuster DW; van der Velden J
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):E7003-12. PubMed ID: 26621701
[TBL] [Abstract][Full Text] [Related]
5. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
[TBL] [Abstract][Full Text] [Related]
6. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic cardiomyopathy mutations increase myofilament Ca
Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
[TBL] [Abstract][Full Text] [Related]
8. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
[TBL] [Abstract][Full Text] [Related]
9. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
Nakashima Y; Kubo T; Sugiura K; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kimura A; Doi YL; Kitaoka H
Circ J; 2020 Sep; 84(10):1846-1853. PubMed ID: 32830170
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
11. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
13. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
[TBL] [Abstract][Full Text] [Related]
14. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
[TBL] [Abstract][Full Text] [Related]
15. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy.
Otsuka H; Arimura T; Abe T; Kawai H; Aizawa Y; Kubo T; Kitaoka H; Nakamura H; Nakamura K; Okamoto H; Ichida F; Ayusawa M; Nunoda S; Isobe M; Matsuzaki M; Doi YL; Fukuda K; Sasaoka T; Izumi T; Ashizawa N; Kimura A
Circ J; 2012; 76(2):453-61. PubMed ID: 22112859
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy.
Theis JL; Bos JM; Theis JD; Miller DV; Dearani JA; Schaff HV; Gersh BJ; Ommen SR; Moss RL; Ackerman MJ
Circ Heart Fail; 2009 Jul; 2(4):325-33. PubMed ID: 19808356
[TBL] [Abstract][Full Text] [Related]
18. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
Chiou KR; Chu CT; Charng MJ
J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
[TBL] [Abstract][Full Text] [Related]
19. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
[TBL] [Abstract][Full Text] [Related]
20. Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes.
Schuldt M; Johnston JR; He H; Huurman R; Pei J; Harakalova M; Poggesi C; Michels M; Kuster DWD; Pinto JR; van der Velden J
J Mol Cell Cardiol; 2021 Jan; 150():77-90. PubMed ID: 33148509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
